1. A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19
- Author
-
Demis N. Lipe, Sorayah S. Bourenane, Monica K. Wattana, Susan Gaeta, Patrick Chaftari, Maria T. Cruz Carreras, Joanna-Grace Manzano, and Cielito Reyes-Gibby
- Subjects
SARS-CoV-2 ,Emergency department ,COVID-19 ,General Medicine ,Length of Stay ,Severity of Illness Index ,Article ,Emergency severity index ,Neoplasms ,ESI ,Emergency Medicine ,Humans ,Triage ,Emergency Service, Hospital ,Retrospective Studies ,Cancer - Abstract
Objective To evaluate a modified emergency severity index (mESI)-based triage of cancer patients with coronavirus disease 2019 (COVID-19) in the emergency department (ED) and determine the associations between mESI level and ED disposition, hospital length of stay, and overall survival. Methods Medical records were retrospectively reviewed for all patients who presented to our institution's ED between March 22, 2020, and March 12, 2021, and tested positive for SARS-CoV-2. Results A total of 306 cancer patients tested positive for SARS-CoV-2, with 45% of patients triaged to level 2 (emergent) and 55% to level 3 (urgent). Among all patients, 61.8% were admitted to the hospital, 15.7% were admitted to the intensive care unit, 2.9% were sent for observation, and 19.6% were discharged. Although demographic and clinical characteristics did not significantly vary by triage level, we observed significant differences in ED length of stay (urgent = 6.67 h, emergent = 5.97 h; p
- Published
- 2022
- Full Text
- View/download PDF